Report Code : CVMI0108 | Published Date : Aug. 1, 2025

Market Overview

Sustained release excipients are essential in pharmaceutical formulations because they enable controlled drug delivery over long periods. These excipients help achieve consistent therapeutic levels, lower dosing frequency, and improve patient compliance. Common excipients include polymers, lipids, gums, and waxes used in oral, injectable, and transdermal dosage forms. As the prevalence of chronic diseases increases and regulatory focus on patient-centered delivery systems grows, the market for sustained release excipients continues to expand.

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

1.93

Based on excipient supplier sales and sustained-release drug formulation trends

2024

3.01

Five-year CAGR 9.4 %

2031

5.82

Seven-year CAGR 10.1 % (2024–2031)

Demand is projected to exceed USD 6 billion by 2031, driven by innovation in oral controlled-release systems and novel biologics stabilization.

Primary Market Drivers

• Rising prevalence of chronic conditions requiring long-term medication (e.g., diabetes, hypertension, epilepsy)
• Growing geriatric population demanding low-frequency dosing formats
• Expanding pipeline of controlled-release generic and branded formulations
• Technological advancements in polymer science and hydrophilic matrices
• Regulatory guidance supporting extended-release delivery platforms

Market Challenges

• Complexity in formulating and scaling up SR dosage forms
• Higher development costs compared to IR systems
• Regulatory scrutiny over excipient safety and interactions with APIs
• Compatibility and stability issues with certain biologicals and peptides
• Limited adoption in emerging markets due to cost concerns

Competitive Landscape

Company / Organization

2024 Share

Core Strengths

Recent Moves

BASF SE

20 %

Polyvinylpyrrolidone, controlled-release polymers

Expanded Kollidon® SR line (Q1 2024)

Evonik Industries

18 %

EUDRAGIT® polymers for oral sustained release

Opened excipient innovation center in Germany (Q3 2024)

Ashland Global

16 %

Cellulose ethers, hydrophilic matrix systems

Launched new grades of Benecel™ for SR tablets (Q2 2024)

Dow Chemical Company

12 %

Methocel™ polymers and oral film formulations

Partnered with CDMOs for SR film technology (Q1 2025)

Others (Colorcon, Gattefossé, Lubrizol)

34 %

Specialized lipid matrices, coatings, and ion exchange resins

Colorcon expanded Surelease® coating capacity (Q2 2025)

Detailed Market Segmentation

By Excipient Type
• Polymers (Cellulose, PVP, Acrylates) – 52 %
• Lipid-Based Excipients – XX %
• Gums & Waxes – XX %
• Others (Ion Exchange Resins, Osmotic Agents) – XX %

By Route of Administration
• Oral – 68 %
• Injectable – XX %
• Transdermal – XX %
• Others (Implants, Buccal) – XX %

By End User
• Pharmaceutical Companies – 59 %
• Contract Manufacturing Organizations (CMOs) – XX %
• Research Institutes – XX %
• Others – XX %

Regional Analysis

• North America (39%) – Strong presence of generics and branded controlled-release drugs
• Europe (XX%) – High investment in SR R&D and regulatory support for excipient safety
• Asia-Pacific (XX%) – Fastest CAGR of 11.6%, driven by India and China’s generic industry scale
• Latin America & MEA (XX%) – Emerging opportunities with increasing chronic disease burden and pharma outsourcing

Technology and Innovation

• Hydrophilic matrix systems enable linear drug release kinetics
• Smart polymers with pH-dependent swelling and erosion control
• Lipid multiparticulates for sustained absorption in the GI tract
• Advanced coatings provide site-specific drug release
• Modular manufacturing lines with precise excipient blending

Regulatory Environment

• US FDA guidance on extended-release oral dosage forms
• EMA focus on excipient safety, compatibility, and IPEC certification
• Chinese NMPA promotes local excipient standardization and innovation
• ISO and ICH Q8/Q9 guidelines on formulation design and risk management

Recent Developments (Q4 2023 – Q2 2025)

• BASF introduced Kollidon® SR+ polymer for modified-release tablets (Q1 2024). 

• Ashland released Benecel™ CR for small-batch personalized meds (Q2 2024). 

• Colorcon expanded coating production in India to meet Asia-Pacific demand (Q2 2025). 

• Evonik collaborated with pharma CDMOs for multi-particulate SR delivery (Q3 2024). 

• Dow launched polymeric oral films integrating SR microspheres (Q1 2025).

Strategic Outlook

• Suppliers should invest in polymer diversification and coating innovations.
• CMOs can benefit by offering excipient-based formulation differentiation.
• Pharma companies should adopt excipient risk profiling to accelerate regulatory approvals.
• Emerging regions present untapped potential in sustained delivery generics.

Methodology

Clearview Market Insights analyzed excipient sales data from 58 suppliers, reviewed 130 SR product filings, and interviewed 46 formulation experts worldwide. Forecasts were built using bottom-up excipient demand modeling across major dosage forms.

About Clearview Market Insights

Clearview Market Insights provides global pharmaceutical ingredient and delivery platform intelligence to formulators, excipient manufacturers, and healthcare investors.





Reasons To Buy

• Track opportunities in chronic disease-oriented drug delivery markets
• Understand regulatory and technical considerations for SR excipients
• Evaluate innovation in polymer science and coating technologies
• Benchmark global and regional players by excipient portfolio and market share





Scope

• Revenue projections for excipient types by route of administration (2019–2031)
• Global segmentation by polymer type, end use, and geography
• Innovation trends in controlled-release delivery formats
• Market share benchmarking for excipient providers

  1. BASF SE
  2. Evonik Industries
  3. Ashland Global
  4. Dow Chemical Company
  5. Colorcon
  6. Gattefossé
  7. Lubrizol

Global Sustained Release Excipients Market Report


  1. 1. Global Sustained Release Excipients Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Sustained Release Excipients Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Global Sustained Release Excipients Market Research Report - Preface
    1. 2.1 Global Sustained Release Excipients Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Excipient Type
      2. 2.1.2 By Route of Administration
      3. 2.1.3 By End User
      4. 2.1.4 By Region
  3. 3. Global Sustained Release Excipients Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Excipient Type, By Route of Administration, By End User, By Country
    3. 3.3. Opportunities – By Excipient Type, By Route of Administration, By End User, By Country
    4. 3.4. Trends – By Excipient Type, By Route of Administration, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Sustained Release Excipients Market Research Report – DROTs Impact Analysis
    1. 4. Global Sustained Release Excipients Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Global Sustained Release Excipients Market, By Excipient Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Polymers (Cellulose, PVP, Acrylates)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Lipid-Based Excipients
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Gums & Waxes
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 Others (Ion Exchange Resins, Osmotic Agents)
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Sustained Release Excipients Market, By Route of Administration, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Oral
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Injectable
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Transdermal
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 6.4 Others (Implants, Buccal)
    17. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Sustained Release Excipients Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Pharmaceutical Companies
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 Contract Manufacturing Organizations (CMOs)
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Research Institutes
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 7.4 Others
    17. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Global Sustained Release Excipients Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East and Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Global Sustained Release Excipients Market - Opportunity Analysis Index, By Excipient Type, By Route of Administration, By End User, and Region, 2024 - 2031
  1. 9. North America Global Sustained Release Excipients Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Excipient Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Polymers (Cellulose, PVP, Acrylates)
      2. 9.1.2 Lipid-Based Excipients
      3. 9.1.3 Gums & Waxes
      4. 9.1.4 Others (Ion Exchange Resins, Osmotic Agents)
      9.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Oral
      2. 9.2.2 Injectable
      3. 9.2.3 Transdermal
      4. 9.2.4 Others (Implants, Buccal)
      9.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Pharmaceutical Companies
      2. 9.3.2 Contract Manufacturing Organizations (CMOs)
      3. 9.3.3 Research Institutes
      4. 9.3.4 Others
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 U.S
      2. 9.4.2 Canada
    2. 9.5 North America Global Sustained Release Excipients Market – Opportunity Analysis Index, By Excipient Type, By Route of Administration, By End User, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 North America Global Sustained Release Excipients Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (U.S)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Sustained Release Excipients Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Excipient Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Polymers (Cellulose, PVP, Acrylates)
      2. 10.1.2 Lipid-Based Excipients
      3. 10.1.3 Gums & Waxes
      4. 10.1.4 Others (Ion Exchange Resins, Osmotic Agents)
      10.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Oral
      2. 10.2.2 Injectable
      3. 10.2.3 Transdermal
      4. 10.2.4 Others (Implants, Buccal)
      10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Pharmaceutical Companies
      2. 10.3.2 Contract Manufacturing Organizations (CMOs)
      3. 10.3.3 Research Institutes
      4. 10.3.4 Others
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 UK
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Poland and Rest of Europe
    2. 10.5 Europe Global Sustained Release Excipients Market – Opportunity Analysis Index, By Excipient Type, By Route of Administration, By End User, and Country, 2024 - 2031
    3. 10.6 Regional Trends Analysis
    4. 10.7 Europe Global Sustained Release Excipients Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (UK)
      3. 10.7.3 Company 3 (UK)
    11. Asia-Pacific Global Sustained Release Excipients Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Excipient Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Polymers (Cellulose, PVP, Acrylates)
      2. 11.1.2 Lipid-Based Excipients
      3. 11.1.3 Gums & Waxes
      4. 11.1.4 Others (Ion Exchange Resins, Osmotic Agents)
      11.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Oral
      2. 11.2.2 Injectable
      3. 11.2.3 Transdermal
      4. 11.2.4 Others (Implants, Buccal)
      11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Pharmaceutical Companies
      2. 11.3.2 Contract Manufacturing Organizations (CMOs)
      3. 11.3.3 Research Institutes
      4. 11.3.4 Others
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Japan
      2. 11.4.2 China
      3. 11.4.3 India
      4. 11.4.4 ASEAN
      5. 11.4.5 Australia & New Zealand
      6. 11.4.6 Rest of Asia-Pacific
    2. 11.5 Asia-Pacific Global Sustained Release Excipients Market – Opportunity Analysis Index, By Excipient Type, By Route of Administration, By End User, and Country, 2024 - 2031
    3. 11.6 Regional Trends Analysis
    4. 11.7 Asia-Pacific Global Sustained Release Excipients Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (Japan)
      2. 11.7.2 Company 2 (China)
      3. 11.7.3 Company 3 (China)
    12. Latin America Global Sustained Release Excipients Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Excipient Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Polymers (Cellulose, PVP, Acrylates)
      2. 12.1.2 Lipid-Based Excipients
      3. 12.1.3 Gums & Waxes
      4. 12.1.4 Others (Ion Exchange Resins, Osmotic Agents)
      12.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Oral
      2. 12.2.2 Injectable
      3. 12.2.3 Transdermal
      4. 12.2.4 Others (Implants, Buccal)
      12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Pharmaceutical Companies
      2. 12.3.2 Contract Manufacturing Organizations (CMOs)
      3. 12.3.3 Research Institutes
      4. 12.3.4 Others
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Rest of Latin America
    2. 12.5 Latin America Global Sustained Release Excipients Market – Opportunity Analysis Index, By Excipient Type, By Route of Administration, By End User, and Country, 2024 - 2031
    3. 12.6 Regional Trends Analysis
    4. 12.7 Latin America Global Sustained Release Excipients Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East and Africa Global Sustained Release Excipients Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Excipient Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Polymers (Cellulose, PVP, Acrylates)
      2. 13.1.2 Lipid-Based Excipients
      3. 13.1.3 Gums & Waxes
      4. 13.1.4 Others (Ion Exchange Resins, Osmotic Agents)
      13.2 By Route of Administration Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Oral
      2. 13.2.2 Injectable
      3. 13.2.3 Transdermal
      4. 13.2.4 Others (Implants, Buccal)
      13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Pharmaceutical Companies
      2. 13.3.2 Contract Manufacturing Organizations (CMOs)
      3. 13.3.3 Research Institutes
      4. 13.3.4 Others
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Gulf Cooperation Council (GCC) Countries
      2. 13.4.2 Israel
      3. 13.4.3 South Africa
      4. 13.4.4 Rest of MEA
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
    2. 13.5 Middle East and Africa Global Sustained Release Excipients Market – Opportunity Analysis Index, By Excipient Type, By Route of Administration, By End User, and Country, 2024 - 2031
    3. 13.6 Regional Trends Analysis
    4. 13.7 Middle East and Africa Global Sustained Release Excipients Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Gulf Cooperation Council (GCC) Countries)
      2. 13.7.2 Company 2 (Israel)
      3. 13.7.3 Company 3 (Israel)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 BASF SE
      2. 14.2.2 Evonik Industries
      3. 14.2.3 Ashland Global
      4. 14.2.4 Dow Chemical Company
      5. 14.2.5 Colorcon
      6. 14.2.6 Gattefossé
      7. 14.2.7 Lubrizol
  1. 15. Data Collection Method and Research Approach
  1. 16. Principal Presumptions and Acronyms